Funding
The Office’s team and activities are supported by several competitive projects to which the office plays/ed a key role in the design, elaboration and/or execution, notably:
– CEECINST/00041/2018 (FCT), cofunded by project GOOD4U (COMPETE2020-FEDER)
– UC-BIOTECH – Valor (CENTRO2020-FSE)
– DYNABrain (European Commission-H2020)
– PAS GRAS (European Commission-HE)
– EXCELScIOR (European Commission-HE)
At institutional level, we are funded by the CIBB UID pluriannual projects UIDB/04539/2020 and UIDP/04539/2020, as well as by the CIBB Associate Laboratory project LA/P/0058/2020.
The institution is also funded by researcher-driven competitive funding from multiple sources, including:
Public Institutions
FCT, COMPETE | CENTRO (2030) (ESIF), Ciência Viva, Infarmed, European Commission, Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH).
Private Institutions
Bial, Bluepharma, Santa Casa da Misericórdia, Fundação Calouste Gulbenkian, Maratona da Saúde, “la Caixa” Foundation, AFM-Téléthon, Jérôme Lejeune Foundation,Laboratoire INNOTECH International – Innothera, Medical Research Council, Bayer, Novartis, Roche, European Association for the Study of Diabetes (EASD), Merck, Blade Therapeutics, Wave Life Sciences, Alzheimer's Foundation of America, Brain & Behaviour Research Foundation, National Ataxia Foundation, The Michael J. Fox Foundation, Progeria Research Foundation, Teva Pharmaceutical, BioBlast Pharma, Mizutani Foundation for Glycoscience.
A comprehensive list of projects and funding entities supporting our activities can be browsed here.